D. Reymen

868 total citations
18 papers, 709 citations indexed

About

D. Reymen is a scholar working on Epidemiology, Virology and Infectious Diseases. According to data from OpenAlex, D. Reymen has authored 18 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Virology and 8 papers in Infectious Diseases. Recurrent topics in D. Reymen's work include HIV Research and Treatment (9 papers), Cytomegalovirus and herpesvirus research (9 papers) and HIV/AIDS drug development and treatment (8 papers). D. Reymen is often cited by papers focused on HIV Research and Treatment (9 papers), Cytomegalovirus and herpesvirus research (9 papers) and HIV/AIDS drug development and treatment (8 papers). D. Reymen collaborates with scholars based in Belgium, United States and France. D. Reymen's co-authors include Erik De Clercq, Graciela Andreï, Robert Snoeck, José A. Esté, Myriam Witvrouw, Jan Desmyter, Jan Balzarini, Satoru Ikeda, Yves Pommier and Lieve Naesens and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Biochemical Pharmacology.

In The Last Decade

D. Reymen

18 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Reymen Belgium 13 265 260 255 182 93 18 709
Emma A. Harden United States 16 738 2.8× 239 0.9× 231 0.9× 184 1.0× 131 1.4× 30 1.1k
Chermann Jc France 14 69 0.3× 132 0.5× 120 0.5× 163 0.9× 109 1.2× 55 566
S Kuno Japan 11 115 0.4× 256 1.0× 252 1.0× 293 1.6× 61 0.7× 20 756
Sabrina Auerochs Germany 19 796 3.0× 136 0.5× 130 0.5× 450 2.5× 102 1.1× 21 1.2k
Shilpa R. Shenoy United States 14 131 0.5× 199 0.8× 282 1.1× 743 4.1× 306 3.3× 21 1.2k
Sabine Rechter Germany 8 631 2.4× 60 0.2× 112 0.4× 345 1.9× 66 0.7× 8 974
Luke A. Pallansch United States 15 119 0.4× 314 1.2× 347 1.4× 352 1.9× 62 0.7× 24 763
Elena Gustchina United States 15 63 0.2× 395 1.5× 502 2.0× 317 1.7× 79 0.8× 19 869
Teresa H. Bacon United Kingdom 12 597 2.3× 123 0.5× 97 0.4× 142 0.8× 79 0.8× 17 825
Kunlong Ben China 13 212 0.8× 322 1.2× 282 1.1× 160 0.9× 32 0.3× 38 771

Countries citing papers authored by D. Reymen

Since Specialization
Citations

This map shows the geographic impact of D. Reymen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Reymen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Reymen more than expected).

Fields of papers citing papers by D. Reymen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Reymen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Reymen. The network helps show where D. Reymen may publish in the future.

Co-authorship network of co-authors of D. Reymen

This figure shows the co-authorship network connecting the top 25 collaborators of D. Reymen. A scholar is included among the top collaborators of D. Reymen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Reymen. D. Reymen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Swart, Pieter, Myriam Witvrouw, José A. Esté, et al.. (1999). Anti-HIV-1 Activity of Combinations and Covalent Conjugates of Negatively Charged Human Serum Albumins (NCAs) and AZT. Journal of drug targeting. 6(5). 323–335. 11 indexed citations
2.
Vreese, K De, D. Reymen, Philip Griffin, et al.. (1996). The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding. Antiviral Research. 29(2-3). 209–219. 50 indexed citations
3.
Reymen, D., Myriam Witvrouw, José A. Esté, et al.. (1996). Mechanism of the Antiviral Activity of New Aurintricarboxylic Acid Analogues. Antiviral chemistry & chemotherapy. 7(3). 142–152. 14 indexed citations
4.
Leydet, Alain, Bernard Boyer, G. Lamaty, et al.. (1996). Polyanion Inhibitors of Human Immunodeficiency Virus and Other Viruses. Part 2. Polymerized Anionic Surfactants Derived from Amino Acids and Dipeptides. Journal of Medicinal Chemistry. 39(8). 1626–1634. 18 indexed citations
5.
Leydet, Alain, Philippe Barthélémy, Bernard Boyer, et al.. (1995). Polyanion Inhibitors of Human Immunodeficiency Virus and Other Viruses. 1. Polymerized Anionic Surfactants. Journal of Medicinal Chemistry. 38(13). 2433–2440. 19 indexed citations
6.
Andreï, Graciela, Robert Snoeck, D. Reymen, et al.. (1995). Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus. European Journal of Clinical Microbiology & Infectious Diseases. 14(4). 318–329. 57 indexed citations
7.
Cushman, Mark, W. Marek Gołębiewski, Yves Pommier, et al.. (1995). Cosalane Analogs with Enhanced Potencies as Inhibitors of HIV-1 Protease and Integrase. Journal of Medicinal Chemistry. 38(3). 443–452. 63 indexed citations
8.
Reymen, D., Lieve Naesens, Jan Balzarini, Antonı́n Holý, & Erik De Clercq. (1995). Antiviral Activity of Selected Nucleoside Analogues Against Human Herpes Virus Type 6. Nucleosides Nucleotides & Nucleic Acids. 14(3). 567–570. 6 indexed citations
9.
Reymen, D., Lieve Naesens, Jan Balzarini, et al.. (1995). Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral Research. 28(4). 343–357. 77 indexed citations
10.
Reymen, D., et al.. (1995). Antiviral activity of selected nucleoside analogues against human herpes virus type 6. Antiviral Research. 26(3). A326–A326. 5 indexed citations
11.
Cushman, Mary, D. Reymen, José A. Esté, et al.. (1995). Anti-HIV and anti-HCMV Activities of New Aurintricarboxylic Acid Analogues. Antiviral chemistry & chemotherapy. 6(3). 179–186. 3 indexed citations
12.
Ojwang, J O, Robert W. Buckheit, Yves Pommier, et al.. (1995). T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1. Antimicrobial Agents and Chemotherapy. 39(11). 2426–2435. 93 indexed citations
13.
Neyts, Johan, D. Reymen, Didier Letourneur, et al.. (1995). Differential antiviral activity of derivatized dextrans. Biochemical Pharmacology. 50(6). 743–751. 42 indexed citations
14.
Damonte, Elsa B., Johan Neyts, Carlos A. Pujol, et al.. (1994). Antiviral activity of a sulphated polysaccharide from the red seaweed nothogenia fastigiata. Biochemical Pharmacology. 47(12). 2187–2192. 67 indexed citations
15.
Snoeck, Robert, Catherine Sadzot‐Delvaux, Graciela Andreï, et al.. (1994). Meningoradiculoneuritis due to acyclovir‐resistant varicella zoster virus in an acquired immune deficiency syndrome patient. Journal of Medical Virology. 42(4). 338–347. 50 indexed citations
16.
Witvrouw, Myriam, José A. Esté, D. Reymen, et al.. (1994). Activity of a Sulfated Polysaccharide Extracted from the Red Seaweed Aghardhiella Tenera against Human Immunodeficiency Virus and Other Enveloped Viruses. Antiviral chemistry & chemotherapy. 5(5). 297–303. 89 indexed citations
17.
Snoeck, Robert, Graciela Andreï, Jan Balzarini, D. Reymen, & Erik De Clercq. (1994). Dipyridamole Potentiates the Activity of Various Acyclic Nucleoside Phosphonates against Varicella-Zoster Virus, Herpes Simplex Virus and Human Cytomegalovirus. Antiviral chemistry & chemotherapy. 5(5). 312–321. 9 indexed citations
18.
Witvrouw, Myriam, Rudi Pauwels, Anne–Mieke Vandamme, et al.. (1992). Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335. Antimicrobial Agents and Chemotherapy. 36(12). 2628–2633. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emma A. Harden Breakdown of academic impact, for papers by Chermann Jc Breakdown of academic impact, for papers by S Kuno Breakdown of academic impact, for papers by Sabrina Auerochs Breakdown of academic impact, for papers by Shilpa R. Shenoy Breakdown of academic impact, for papers by Sabine Rechter Breakdown of academic impact, for papers by Luke A. Pallansch Breakdown of academic impact, for papers by Elena Gustchina Breakdown of academic impact, for papers by Teresa H. Bacon Breakdown of academic impact, for papers by Kunlong Ben
Rankless by CCL
2026